Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS

The COVID-19 pandemic caused by the novel SARS-CoV-2 is more contagious than other coronaviruses and has higher rates of mortality than influenza. As no vaccine or drugs are currently approved to specifically treat COVID-19, identification of effective therapeutics is crucial to treat the afflicted...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Res Sq
Prif Awduron: O’Donovan, Sinead M, Eby, Hunter, Henkel, Nicholas D, Creeden, Justin, Imami, Ali, Asah, Sophie, Zhang, Xiaolu, Wu, Xiaojun, Alnafisah, Rawan, Taylor, R. Travis, Reigle, James, Thorman, Alexander, Shamsaei, Behrouz, Meller, Jarek, McCullumsmith, Robert E
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Journal Experts 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7336712/
https://ncbi.nlm.nih.gov/pubmed/32702077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-25643/v1
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg